March 15, 2017 / 12:29 PM / 7 months ago

BRIEF-Novelion Therapeutics qtrly non-gaap loss per share basic $1.72

March 15 (Reuters) - Novelion Therapeutics Inc

* Novelion therapeutics reports preliminary fourth quarter & full year 2016 financial results

* Novelion therapeutics inc- company reiterated net product sales financial guidance for full year 2017

* Novelion therapeutics inc- gaap total net product sales for q4 of 2016 were $13.6 million compared to prior year’s q4 revenues of $0 million

* Novelion therapeutics inc qtrly loss per share $1.50

* Novelion therapeutics inc qtrly non-gaap loss per share basic $1.72 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below